AARON L SAMSULA
Allopathic & Osteopathic Physicians|Internal Medicine PLANO, TX NPI 1508971011
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine TX ABBVIE INC. All categories
General Payments — all program years on this page
$13,829.61
- Category: General Payments
- Program years: PY2018–2024
- Record count: 657
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,129.69 across 115 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,129.69 | 115 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $397.28 | 27 |
| Lilly USA, LLC | $307.21 | 17 |
| Novo Nordisk AS | $250.72 | 13 |
| PFIZER INC. | $170.19 | 9 |
| Amgen Inc. | $160.34 | 12 |
| Cleerly, Inc. | $142.67 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $100.51 | 5 |
| Acerta Pharma LLC | $63.86 | 4 |
| GlaxoSmithKline, LLC. | $63.56 | 3 |
| Abbott Laboratories | $54.51 | 3 |
| SANOFI-AVENTIS U.S. LLC | $46.71 | 2 |
| Radius Health, Inc. | $45.04 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $43.94 | 2 |
| Janssen Biotech, Inc. | $42.65 | 2 |
| Sumitomo Pharma America, Inc. | $39.44 | 2 |
| Inspire Medical Systems, Inc. | $34.17 | 1 |
| E.R. Squibb & Sons, L.L.C. | $23.26 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.83 | 1 |
| Janssen Pharmaceuticals, Inc | $20.59 | 1 |
| DEXCOM, INC. | $19.18 | 1 |
| Kowa Pharmaceuticals America, Inc. | $18.27 | 1 |
| DePuy Synthes Sales Inc. | $16.30 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $16.07 | 1 |
| Esperion Therapeutics, Inc. | $15.37 | 1 |
| Astellas Pharma US Inc | $15.02 | 1 |
By program year
Records — PY2024 (115)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.